W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE
At the American Heart Association Virtual Scientific Sessions 2020.
GORE® Molding & Occlusion Balloon for Endovascular Aortic Repair Receives Approval in the United States, Japan, and Europe
New balloon that addresses EVAR stent graft seal and temporary vessel occlusion challenges
Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta
GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta
Gore Acquires Pipeline Medical Technologies, Inc.
Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities
First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry
Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Antegrade iteration accepted into study – advancing this branched, all-in-one system
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions